We provide our customers with facile technology to separate each increment of the nanoparticle mixture prior to detection and provide a true size distribution even for polydispersed samples. the process can be used to separate and size lipid nanoparticles, liposomes , viruses, plasma proteins, and engineered nanoparticles, within minutes per sample.
The 2020 Covid-19 pandemic showcased the power of nanomedicine to the world. Today, more than ever, we need technologies to help increase the impact of nanomedicine for a more effective, and more affordable healthcare. Imessa Research is poised to take the challenge. Our technology can be used to:
-Accurately measure size distribution of nanoparticles
-Separate nanoparticles from impurities and aggregates
-Analyze lipid nanoparticles at various stages
-Detect aggregation
-Evaluate shelf life
Contact us for a free consultation.
Enabling manufacturers of today for tomorrow's nanomedicine